| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/26/2023 | 90.48% | JMP Securities | $4 → $6 | Maintains | Market Outperform |
| 06/26/2023 | 26.98% | JMP Securities | → $4 | Reiterates | Market Outperform → Market Outperform |
| 05/18/2023 | 26.98% | JMP Securities | $4 → $4 | Reiterates | Market Outperform → Market Outperform |
| 10/18/2022 | 26.98% | JMP Securities | → $4 | Initiates Coverage On | → Market Outperform |
| 09/23/2022 | 26.98% | HC Wainwright & Co. | $10 → $4 | Maintains | Buy |
| 02/17/2022 | 217.46% | HC Wainwright & Co. | → $10 | Initiates Coverage On | → Buy |
| 10/05/2020 | — | Ladenburg Thalmann | Downgrades | Buy → Neutral |
What is the target price for Benitec Biopharma (BNTC)?
The latest price target for Benitec Biopharma (NASDAQ: BNTC) was reported by JMP Securities on September 26, 2023. The analyst firm set a price target for $6.00 expecting BNTC to rise to within 12 months (a possible 90.48% upside). 4 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Benitec Biopharma (BNTC)?
The latest analyst rating for Benitec Biopharma (NASDAQ: BNTC) was provided by JMP Securities, and Benitec Biopharma maintained their market outperform rating.
When is the next analyst rating going to be posted or updated for Benitec Biopharma (BNTC)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Benitec Biopharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Benitec Biopharma was filed on September 26, 2023 so you should expect the next rating to be made available sometime around September 26, 2024.
Is the Analyst Rating Benitec Biopharma (BNTC) correct?
While ratings are subjective and will change, the latest Benitec Biopharma (BNTC) rating was a maintained with a price target of $4.00 to $6.00. The current price Benitec Biopharma (BNTC) is trading at is $3.15, which is out of the analyst's predicted range.